What is Celldex Therapeutics Inc (CLDX)?
Celldex Therapeutics Inc is a biopharmaceutical company engaged in the development of immunotherapy treatments for cancer and other diseases. The company focuses on creating monoclonal antibodies and vaccine-based therapies that stimulate the immune system to target diseased cells. Its pipeline includes investigational products for various oncology indications and neurological disorders. Celldex Therapeutics conducts clinical trials to evaluate the safety and efficacy of its candidates. The company collaborates with research institutions and industry partners to advance its therapeutic programs. It emphasizes translational research to bridge laboratory discoveries with clinical applications. Celldex operates research and development facilities dedicated to immuno-oncology and neuroimmunology. Its mission centers on developing novel therapies to address unmet medical needs.
Celldex Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by live market movements, with Celldex Therapeutics Inc at $30.95. The intraday price range is between $29.58 and $31.69, showing a daily percentage move of 0%.
FAQ: Celldex Therapeutics Inc (CLDX)
What is the current price of CLDX stock?
Celldex Therapeutics Inc is currently trading at $30.95.
Does CLDX pay dividends?
Celldex Therapeutics Inc does not pay dividends.
Does CLDX have a formal corporate presence or regional headquarters in the UAE?
Celldex Therapeutics Inc operates in the UAE through partnerships without a direct office or subsidiary.
What is CLDX best known for?
Celldex Therapeutics Inc is most famous for developing immunotherapy treatments for cancer.
What assets are typically shown together with CLDX?
Commonly shown alongside CLDX: Universal Corp, Polynovo Limited, Omeros Corp
Latest shares articles



